Back to results
US 2013/0295046 A1Published application
Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
OwnerHideho Okadainventor
Life of this patent
Estimating the term…
Abstract
Provided herein are interleukin-13 receptor α2 peptide-based brain cancer vaccines and methods for treating and vaccinating against brain cancer comprising administering to patients in need thereof interleukin-13 receptor α2 peptide-based brain cancer vaccines. Also provided herein are regimens comprising interleukin-13 receptor α2 peptides and at least one additional peptide and/or immunostimulant.
Claims1
A pharmaceutical composition comprising an IL-13Rα2 peptide, an EphA2 peptide, a survivin peptide, and a WT1 peptide.
Dependencies are inferred from the claim text.